Duchenne muscular dystrophy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Genetically confirmed as Duchenne muscular dystrophy No limitation of disease stage. No limitation of general condition. No limitation of organ function (motor function, respiratory failure, cardiac failure, and dysphagia). Patients with written informed consent. In case of unable to make decision because of the age under 16 years or mental retardation, patient with written informed consent by parents or legal guardian.
Exclusion criteria
Exclusion criteria: Subject meets any of the following criteria is not enrolled in the study. Not confirmed the diagnosis of DMD. Subject considered to be an unsuitable candidate for the study by the Principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to death | — |
Secondary
| Measure | Time frame |
|---|---|
| Time at loss of ambulation | — |
Countries
Japan
Contacts
National Hospital Organization Osaka Toneyama Medical Center Clinical research center